CSL, a global leader in biotechnology, has once again been recognized as one of America’s Best Employers by Forbes and Statista. This is a testament to CSL’s commitment to providing the best possible work environment and opportunities for its employees.
For the second year in a row, CSL has been recognized by Forbes as one of America’s Best Large-sized Employers. This is the fourth time the company has made the list since 2018, affirming its commitment to providing a great work environment and engaging its employees. With its inclusion on the Forbes list in 2022, 2019, and 2018, CSL is well on its way to becoming one of the leading employers in the United States.
CSL is a global leader in healthcare and biotechnology with 32,000 employees worldwide. In the U.S., CSL operates over 300 plasma donation centers, two manufacturing sites in Kankakee, Illinois, and Holly Springs, North Carolina, and an R&D hub in Pasadena, California. Its U.S. headquarters is located in King of Prussia, Pennsylvania, where CSL Behring’s operational headquarters is based. From small towns to big cities, CSL is committed to providing innovative healthcare solutions to people everywhere.
Forbes has released its annual rankings of the top 500 large employers, based on responses from nearly 45,000 employees from businesses with 5,000 or more employees. Employees were asked to rate their willingness to recommend their employers to their friends and family, and to nominate other companies to be included in the list. The final rankings are based on the highest number of recommendations received, offering an invaluable insight into the best places to work for in the country.
In the past year, CSL has earned its place on two prestigious lists: Forbes’ Global 2000 and Switzerland’s Best Employers. This recognition is a testament to CSL’s commitment to providing a rewarding and engaging work experience for its employees and customers.
Since our founding in 1916, CSL has been determined to save lives through the power of modern biotechnology. Our three divisions, CSL Behring, CSL Seqirus, and CSL Vifor, provide lifesaving medicines and vaccines to patients in more than 100 countries. We have developed treatments for hemophilia, immune deficiencies, influenza, iron deficiency, dialysis, and nephrology. Our commitment to innovation and excellence has enabled us to create treatments that give people the chance to live life to the fullest. With 32,000 employees working together, CSL is a global leader in the biotechnology industry.